Heron Therapeutics Inc vs Public Storage — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while Public Storage trades at $310.13 (market cap $55.40B). The key difference: Public Storage is far larger — about 605.7× Heron Therapeutics Inc's market cap, and Public Storage pays a 3.8% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | PSA | |
|---|---|---|
Market Cap | $91.46M | $55.40B |
Sector | Health | Real Estate |
52-Week High | $1.96 | $329.64 |
52-Week Low | $0.39 | $258.44 |
Enterprise Value | $189.36M | $69.65B |
Dividend Yield | — | 3.8% |
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
Public Storage (PSA) trades at $315.45, down 0.81% on the day, with a neutral technical signal and mixed moving averages. The company shows strong profitability with 39.16% net income margin and 33.78% ROE, though valuation ratios appear elevated with P/E of 32.86. Recent developments include the pending acquisition of National Storage Affiliates and consistent earnings beats in recent quarters.
The outlook remains cautiously optimistic with a $332.25 consensus price target representing 5.3% upside. Key opportunities include expansion into Canadian markets and operational efficiencies, while risks involve integration challenges from acquisitions and potential interest rate sensitivity. Analyst consensus leans neutral with 65.72% hold ratings amid valuation concerns.
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →